APA (7th ed.) Citation

Han, D. H., Kim, W., Lee, C., Park, S., Lee, K., Jang, S. J., & Ko, G. (2022). Co-administration of Lactobacillus gasseri KBL697 and tumor necrosis factor-alpha inhibitor infliximab improves colitis in mice. Scientific reports, 12(1), 9640-9. https://doi.org/10.1038/s41598-022-13753-6

Chicago Style (17th ed.) Citation

Han, Dae Hee, Woon-ki Kim, Cheonghoon Lee, SungJun Park, Kiuk Lee, Sung Jae Jang, and GwangPyo Ko. "Co-administration of Lactobacillus Gasseri KBL697 and Tumor Necrosis Factor-alpha Inhibitor Infliximab Improves Colitis in Mice." Scientific Reports 12, no. 1 (2022): 9640-9. https://doi.org/10.1038/s41598-022-13753-6.

MLA (9th ed.) Citation

Han, Dae Hee, et al. "Co-administration of Lactobacillus Gasseri KBL697 and Tumor Necrosis Factor-alpha Inhibitor Infliximab Improves Colitis in Mice." Scientific Reports, vol. 12, no. 1, 2022, pp. 9640-9, https://doi.org/10.1038/s41598-022-13753-6.